Uncovering Institutional Buying In Aramark (NYSE: ARMK)

The Vanguard Group, Inc. recently announced the acquisition of new stake in Aramark (NYSE:ARMK). The institutional investor has increased its shareholding in the Industrials company by 0.56% to 24.91 million shares with purchase of 0.14 million shares. This fresh investment now brings its stake to 9.52% valued currently at $697.63 million. In addition, BlackRock Fund Advisors raised its holdings by 0.54 million to 20.58 million shares. And Farallon Capital Management LLC has lifted its position by 26.74% or 3.24 million shares – to 15.38 million shares.

Currently, there are 261.45M common shares owned by the public and among those 259.70M shares have been available to trade.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Insiders at the company have transacted a total of 77 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 66 of these insider trades were purchases, accounting for 269,889 shares. Insider sales of the common stock occurred on 11 occasions, with total insider shares sold totaling 36,596 shares.

The top 3 mutual fund holders in Aramark are American Balanced Fund, Eaton Vance Atlanta Capital SMID, and Vanguard Total Stock Market ETF. American Balanced Fund owns 16.91 million shares of the company’s stock, all valued at over $473.73 million. Vanguard Total Stock Market ETF bought 12797.0 shares to bring its total holdings to over 8.16 million shares at a value of $228.67 million. Vanguard Total Stock Market ETF now owns shares totaling to 3.12% of the shares outstanding.

However, the script later moved the day high at 27.86, up 1.91%. The company’s stock has a 5-day price change of 2.33% and 2.62% over the past three months. ARMK shares are trading -7.12% year to date (YTD), with the 12-month market performance down to -7.98% lower. It has a 12-month low price of $23.55 and touched a high of $33.01 over the same period. ARMK has an average intraday trading volume of 4.03 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 0.37%, 2.10%, and 1.88% respectively.

Institutional ownership of Aramark (NYSE: ARMK) shares accounts for 101.12% of the company’s 261.45M shares outstanding. Mutual fund holders own 49.42%, while other institutional holders and individual stakeholders account for 52.42% and 16.06% respectively.

It has a market capitalization of $7.25B and a beta (3y monthly) value of 1.47. The stock’s trailing 12-month PE ratio is 10.81, while the earnings-per-share (ttm) stands at $2.57. The company has a PEG of 0.55 and a Quick Ratio of 0.92 with the debt-to-equity ratio at 2.32. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.34% over the week and 1.87% over the month.

Analysts forecast that Aramark (ARMK) will achieve an EPS of $0.37 for the current quarter, $0.26 for the next quarter and $1.9 for 2025. The lowest estimate earnings-per-share for the quarter is $0.31 while analysts give the company a high EPS estimate of $0.45. Comparatively, EPS for the current quarter was $0.41 a year ago. Earnings per share for the fiscal year are expected to decrease by -10.93%, and 25.67% over the next financial year. EPS should grow at an annualized rate of 19.79% over the next five years, compared to 2.75% over the past 5-year period.

Looking at the support for the ARMK, a number of firms have released research notes about the stock. Jefferies stated their Buy rating for the stock in a research note on October 09, 2023, with the firm’s price target at $44-$29.

Most Popular

Related Posts